BioSpace News Archive

Emergent BioSolutions Inc. announced that members of the company’s senior management team will participate in the following investor conferences:.

NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today reported that the company will be participating in three upcoming conferences.

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conferences:

TransCode Therapeutics, Inc. (Nasdaq: RNAZ), an emerging RNA oncology company, created on the belief that cancer can be defeated through the intelligent design and effective delivery of RNA therapeutics, today reported recent business progress and second quarter 2021 financial results.

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the number of biological samples processed with consumables kits has passed the three billion mark – a record that underlines its leadership in enabling molecular laboratories to gain valuable insights in research, combatting diseases and forensics.

Medline ReNewal today announced the launch of a continuing education (CE) course series to help cardiac electrophysiology (EP) clinicians learn more about the fundamentals of cardiac EP lab procedures.

Doximity, Inc. (NYSE: DOCS) today announced that Anna Bryson, CFO, will participate in a virtual fireside chat at Morgan Stanley’s 19th Annual Global Healthcare Conference on Thursday, Sept. 9, 2021, at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Brazilian Health Regulatory Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved Waylivra™ (volanesorsen) as the first treatment for familial chylomicronemia syndrome (FCS) in Brazil.

Disc Medicine today announced the promotions of Will Savage, MD, PhD to Chief Medical Officer and Jonathan Yu to Chief Business Officer.